Vesynta’s mission is to deliver bespoke treatment to every patient, regardless of your age, gender, ethnicity or health status. We enable the precision dosing of life-saving medicines, advancing their safety and effectiveness. Our people aspire to improve health outcomes and experiences for patients, by reducing life-limiting side effects and fatalities.
Vesynta’s blood monitoring platform enables individualised drug analysis by the patient’s bedside. Our innovations combine robotic automation, analytical software and machine learning, to provide clinicians with a universal solution to determine a patient’s medicine exposure.
This data-guided approach supports smarter clinical decisions and personalised dosing regimes tailored to the individual’s pharmacology, ensuring the best possible treatment and care.
If you would like more information about what we do, please contact us at [email protected]
Company’s Keywords:
medical technology, precision medicine, antimicrobial care, therapeutic drug monitoring, pointofcare device, adult breast cancer, medicine exposure analysis, paediatric oncology, clinical pharmacology
<7
<
<2019